PCM
HOLX

Palisade Capital Management’s Hologic HOLX Stock Holding History

Palisade Capital Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8,000
Closed -$294K – 442
2017
Q3 		$294K Buy
+8,000
New +$323K 0.01% 390

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Palisade Capital Management's HOLX Position: Q4 2017 in Review

Palisade Capital Management sold out of Hologic (HOLX) in Q4 2017, closing a stake of 8,000 shares — an estimated $294K sold.

Palisade Capital Management first reported a position in HOLX in Q3 2017 and held it in 1 quarter. The position peaked at $294K in Q3 2017. 472 funds tracked by Wall St. Rank hold HOLX as of Q4 2017.

  • Palisade Capital Management reported no remaining Hologic position as of Q4 2017 after selling out during the quarter.
  • Palisade Capital Management sold 8,000 Hologic shares in Q4 2017, an estimated $294K.
  • Palisade Capital Management first reported a position in Hologic in Q3 2017 and held it in 1 quarter.
  • Palisade Capital Management's Hologic position peaked at $294K in Q3 2017.
  • 472 funds tracked by Wall St. Rank held Hologic as of Q4 2017.

Based on Palisade Capital Management's 13F filing for Q4 2017, filed 9 Feb 2018.